SCHEMBL4206161

SCHEMBL4206161

CCOC(=O)CC(=O)c1cccc(C(=O)OC)c1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 3/20 0.54
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
LOXL2 Q9Y4K0 1/20 0.50
CYP4F2 P78329 3/20 0.49
CYP4A11 Q02928 3/20 0.49
TSHR P16473 2/20 0.46
CREBBP Q92793 1/20 0.45
RAB9A P51151 3/20 0.45
POLB P06746 2/20 0.45
NPC1 O15118 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
BLM P54132 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1505243 0.87 LOXL2 (0.56) ALDH1A1KMT2AMEN1LOXL2CYP4F2
SCHEMBL5166543 0.85 CYP4F2 (0.58) KDM4EALDH1A1KMT2ALOXL2CYP4F2
SCHEMBL1167294 0.84 KMT2A (0.53) KDM4EALDH1A1KMT2AMEN1RAB9A
SCHEMBL13516645 0.83 ALDH1A1 (0.55) KDM4EALDH1A1KMT2AMEN1LOXL2
SCHEMBL382162 0.83 ALDH1A1 (0.56) KDM4EALDH1A1KMT2AMEN1RAB9A
SCHEMBL29902970 0.83 KDM4E (0.51) KDM4EALDH1A1KMT2AMEN1RAB9A
SCHEMBL11772465 0.83 KDM4E (0.51) KDM4EALDH1A1KMT2AMEN1RAB9A
SCHEMBL290760 0.83 RXFP1 (0.52) KDM4EALDH1A1KMT2AMEN1TSHR
SCHEMBL941861 0.82 LOXL2 (0.57) ALDH1A1KMT2AMEN1LOXL2CYP4F2
SCHEMBL5621140 0.81 KMT2A (0.50) KDM4EALDH1A1KMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 US disclosed
US-20090182142-A1 Aromatic Compound FURUKUBO SHIGERU 2009-07-16 US disclosed
US-20090182142-A1 Aromatic Compound FURUKUBO SHIGERU 2009-07-16 US disclosed
US-20090182142-A1 Aromatic Compound FURUKUBO SHIGERU 2009-07-16 US disclosed
EP-1956009-A1 AROMATIC COMPOUND Mitsubishi Tanabe Pharma Corporation (JP) 2008-08-13 EP disclosed
EP-1956009-A1 AROMATIC COMPOUND Mitsubishi Tanabe Pharma Corporation (JP) 2008-08-13 EP disclosed
US-6919335-B2 Administering a therapeutically effective amount of a heterocyclic compound to the patient for the treatment of inosine monophosphate dehydrogenase associated disorders, such as allograft rejection BRISTOL-MYERS SQUIBB CO. (US) 2005-07-19 US disclosed
US-20020040022-A1 Heterocycles that are inhibitors of IMPDH enzyme BRISTOL-MYERS SQUIBB COMPANY 2002-04-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020040022-A1 Heterocycles that are inhibitors of IMPDH enzyme XDH, IMPDH1, IMPDH2 KDM4E 2785/4885ALDH1A1 155/4885KMT2A 3646/4885
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK KDM4E 3207/4885ALDH1A1 290/4885KMT2A 3400/4885
US-20090182142-A1 Aromatic Compound HRH4, CCR4, HRH3 KDM4E 1026/4885ALDH1A1 1906/4885KMT2A 1822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.